WallStSmart

Medtronic PLC (MDT)vsTrip.com Group Ltd ADR (TCOM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Trip.com Group Ltd ADR generates 76% more annual revenue ($62.41B vs $35.48B). TCOM leads profitability with a 53.3% profit margin vs 13.0%. MDT appears more attractively valued with a PEG of 1.50. TCOM earns a higher WallStSmart Score of 81/100 (A-).

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0

TCOM

Exceptional Buy

81

out of 100

Grade: A-

Growth: 9.3Profit: 8.0Value: 10.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTSignificantly Overvalued (-255.7%)

Margin of Safety

-255.7%

Fair Value

$24.34

Current Price

$87.89

$63.55 premium

UndervaluedFair: $24.34Overvalued
TCOMUndervalued (+82.1%)

Margin of Safety

+82.1%

Fair Value

$323.86

Current Price

$51.34

$272.52 discount

UndervaluedFair: $323.86Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$110.62B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

TCOM6 strengths · Avg: 9.7/10
P/E RatioValuation
7.4x10/10

Attractively priced relative to earnings

Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Profit MarginProfitability
53.3%10/10

Keeps 53 of every $100 in revenue as profit

EPS GrowthGrowth
97.8%10/10

Earnings expanding 97.8% YoY

Return on EquityProfitability
21.1%9/10

Every $100 of equity generates 21 in profit

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

TCOM2 concerns · Avg: 4.0/10
PEG RatioValuation
1.914/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bull Case : TCOM

The strongest argument for TCOM centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 53.3% and operating margin at 16.5%. Revenue growth of 20.8% demonstrates continued momentum.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : TCOM

The primary concerns for TCOM are PEG Ratio, Altman Z-Score.

Key Dynamics to Monitor

MDT profiles as a value stock while TCOM is a growth play — different risk/reward profiles.

MDT carries more volatility with a beta of 0.73 — expect wider price swings.

TCOM is growing revenue faster at 20.8% — sustainability is the question.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TCOM scores higher overall (81/100 vs 56/100), backed by strong 53.3% margins and 20.8% revenue growth. Both earn "Exceptional Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Trip.com Group Ltd ADR

CONSUMER CYCLICAL · TRAVEL SERVICES · China

Trip.com Group Limited is a travel service provider for accommodation booking, transportation ticketing, destination and package tours, corporate travel management and other travel-related services in China and internationally. The company is headquartered in Shanghai, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?